Abstract:Objective: Ex vivo lung perfusion has emerged as a novel technique to safely preserve lungs before transplantation. Recent studies have demonstrated an accumulation of inflammatory molecules in the perfusate during ex vivo lung perfusion. These proinflammatory molecules, including damage-associated molecular patterns and inflammatory cytokines, may contribute to acute and chronic allograft dysfunction. At present, ex vivo lung perfusion is performed clinically at normothermic temperature (37°C). The effect of lowering temperature to the subnormothermic range during ex vivo lung perfusion has not been reported. In this study, we hypothesized that lower ex vivo lung perfusion temperature will lead to a reduction in allograft inflammation and result in improved post-transplant graft function. Methods: Lewis rat heart-lung blocs underwent 4 hours of ex vivo lung perfusion in 3 temperature groups: 37°C (MP37), 30°C (MP30), and 25°C (MP25). In the control group, lung grafts were preserved by static cold storage before transplantation. After ex vivo lung perfusion or static cold storage, the left lung was transplanted for 2 hours before the animal was killed. Sera and tissue were collected and analyzed. Results: There were no differences in partial pressure of arterial oxygenation to fraction of inspired oxygen ratios during 4 hours of ex vivo lung perfusion between temperature groups. Tumor necrosis factor α significantly increased in the MP37 group during ex vivo lung perfusion, whereas this was not seen at lower temperatures. Extracellular DNA and high-mobility group box 1 perfusate concentrations increased significantly during ex vivo lung perfusion in all groups, but the rate of increase was diminished at lower temperature. Two hours post-transplant, there were no significant differences in partial pressure of arterial oxygenation to fraction of inspired oxygen ratios of the lung graft or serum damage-associated molecular pattern levels among groups. On histologic grading after transplantation, greater injury was observed in the MP30 and MP37 groups, but not MP25, when compared with static cold storage. Conclusions: Subnormothermic ex vivo lung perfusion at 25°C reduces the production of inflammatory mediators during ex vivo lung perfusion and is associated with reduced histologic graft injury after transplantation.

Therapeutic Use of Carbon Monoxide in Ex-Vivo Lung Perfusion in Donor With Prolonged Cold Ischemia

High-pressure carbon monoxide preserves rat kidney grafts from apoptosis and inflammation

Experimental Research on Protective Effect of Exogenous Carbon Monoxide with Low Dose Inhalation on Donor Lung of Rats

Protective effects by low dose carbon monoxide inhalation on the donor lung of rats

Donor pretreatment with carbon monoxide prevents ischemia/reperfusion injury following heart transplantation in rats

Ventilation with cooled carbon monoxide protects non-heart-beating donor rat lungs against worm ischemic injury

Ventilation with low-dose carbon monoxide protects non-heart-beating donor rat lungs against worm ischemic injury

The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.

Argon and xenon ventilation during prolonged ex vivo lung perfusion

The Protective Effects of Carbon Monoxide Against Hepatic Warm Ischemia-Reperfusion Injury in MHC-Inbred Miniature Swine

Ex Vivo Lung Perfusion with K(ATP) Channel Modulators Antagonize Ischemia Reperfusion Injury

Successful 3-day lung preservation using a cyclic normothermic ex vivo lung perfusion strategy

Ex vivo lung perfusion with perfusate purification for human donor lungs following prolonged cold storage

Ex Vivo Lung Perfusion with β-Nicotinamide Adenine Dinucleotide (NAD+) Improves Ischemic Lung Function

Carbon monoxide as an emerging pharmacological tool to improve lung and liver transplantation protocols

Subnormothermic ex vivo lung perfusion attenuates graft inflammation in a rat transplant model

β2-Adrenoreceptor Agonist Inhalation During Ex Vivo Lung Perfusion Attenuates Lung Injury

The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation

The Effect of Carbon Monoxide Inhalation on the Apoptosis of the Donor Lung of Rats

Hydrogen gas inhalation during ex vivo lung perfusion of donor lungs recovered after cardiac death

Prone ex vivo lung perfusion protects human lungs from reperfusion injury